Literature DB >> 16698549

GTP-Ras disrupts the intramolecular complex of C1 and RA domains of Nore1.

Elena Harjes1, Stefan Harjes, Sabine Wohlgemuth, Karl-Heinz Müller, Elmar Krieger, Christian Herrmann, Peter Bayer.   

Abstract

The novel Ras effector mNore1, capable of inducing apoptosis, is a multidomain protein. It comprises a C1 domain homologous to PKC and an RA domain similar to the Ras effectors AF-6 and RalGDS. Here, we determine the affinity of these two domains to the active forms of Ras and Rap1 using isothermal calorimetric titration. The interaction of Ras/Rap1-GTP with the RA domain of mNore1 is weakened significantly by direct binding of the C1 domain to the RA domain. In order to analyze this observation in atomic detail, we solved the C1 solution structure by NMR. By determining chemical shifts and relaxation rates, we can show an intramolecular complex of C1-RA. GTP-Ras titration and binding to RA disrupts this complex and displaces the C1 domain. Once the C1 domain tumbles freely in solution, a lipid binding interface becomes accessible. Furthermore, we provide evidence of phosphatidylinositol 3-phosphate binding of the free C1 domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698549     DOI: 10.1016/j.str.2006.03.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  30 in total

1.  T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes.

Authors:  Monika Raab; Hongyan Wang; Yuning Lu; Xin Smith; Zhonglin Wu; Klaus Strebhardt; John E Ladbury; Christopher E Rudd
Journal:  Immunity       Date:  2010-03-25       Impact factor: 31.745

Review 2.  Intrinsic protein disorder in oncogenic KRAS signaling.

Authors:  Ruth Nussinov; Hyunbum Jang; Chung-Jung Tsai; Tsung-Jen Liao; Shuai Li; David Fushman; Jian Zhang
Journal:  Cell Mol Life Sci       Date:  2017-06-08       Impact factor: 9.261

3.  Probing the determinants of diacylglycerol binding affinity in the C1B domain of protein kinase Cα.

Authors:  Mikaela D Stewart; Brittany Morgan; Francesca Massi; Tatyana I Igumenova
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

Review 4.  Tumor suppressor C-RASSF proteins.

Authors:  Hiroaki Iwasa; Shakhawoat Hossain; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2018-01-20       Impact factor: 9.261

5.  RASSF1A: Not a prototypical Ras effector.

Authors:  Marilyn Gordon; Shairaz Baksh
Journal:  Small GTPases       Date:  2011-05

6.  Ras homolog enriched in brain (Rheb) enhances apoptotic signaling.

Authors:  Sascha Karassek; Carsten Berghaus; Melanie Schwarten; Christoph G Goemans; Nadine Ohse; Gerd Kock; Katharina Jockers; Sebastian Neumann; Sebastian Gottfried; Christian Herrmann; Rolf Heumann; Raphael Stoll
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

Review 7.  Rassf family of tumor suppressor polypeptides.

Authors:  Joseph Avruch; Ramnik Xavier; Nabeel Bardeesy; Xian-Feng Zhang; Maria Praskova; Dawang Zhou; Fan Xia
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

8.  Binding the atypical RA domain of Ste50p to the unfolded Opy2p cytoplasmic tail is essential for the high-osmolarity glycerol pathway.

Authors:  Irena Ekiel; Traian Sulea; Gregor Jansen; Maria Kowalik; Ovidiu Minailiuc; Jing Cheng; Doreen Harcus; Miroslaw Cygler; Malcolm Whiteway; Cunle Wu
Journal:  Mol Biol Cell       Date:  2009-12       Impact factor: 4.138

9.  Dynamics of RASSF1A/MOAP-1 association with death receptors.

Authors:  Caitlin J Foley; Holly Freedman; Sheryl L Choo; Christina Onyskiw; Nai Yang Fu; Victor C Yu; Jack Tuszynski; Joanne C Pratt; Shairaz Baksh
Journal:  Mol Cell Biol       Date:  2008-05-12       Impact factor: 4.272

10.  Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.

Authors:  Benjamin Stieglitz; Christine Bee; Daniel Schwarz; Ozkan Yildiz; Anna Moshnikova; Andrei Khokhlatchev; Christian Herrmann
Journal:  EMBO J       Date:  2008-07-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.